Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats

Diabetes

Volumn 46, Issue 5, 1997, Pages 841-846

  Gagné, Joël ^a   Milot, Martin ^a   Gélinas, Sylvie ^a   Lahsaïni, Ahmed ^a   Trudeau, François ^a   Martinoli, Maria Grazia ^a   Massicotte, Guy ^a,b  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b Institut Philippe Pinel de Montreal   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE; STREPTOZOCIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DIABETES MELLITUS; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STREPTOZOCIN DIABETES;

EID: 0030992061     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.5.841     Document Type: Article

References (40)

1. Ryan C, Vega A, Drash A: Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75:921-927, 1985
2. Mooradian AD, Perryman K, Fitten J, Kavonian G, Morley JE: Cortical function in elderly non-insulin dependent diabetic patients: behavioral and electrophysiological studies. Arch Intern Med 148:2369-2372, 1988
3. Mooradian AD: Tissue specificity of premature aging in diabetes mellitus: the role of cellular replicative capacity. J Am Geriatr Soc 36:831-839, 1988
4. Bellush LL, Rowland NE: Stress and behavior in streptozotocin diabetic rats: biochemical correlates of passive avoidance learning. Behav Neurosci 103:144-150, 1989
5. Flood JF, Mooradian AD, Morley JE: Characteristics of learning and memory in streptozotocin-induced diabetic mice. Diabetes 39:1391-1398, 1990
6. Bitar M, Koulu M, Rapoport SI, Linnoila M: Diabetes-induced alteration in brain monoamine metabolism in rats. J Pharmacol Exp Ther 236:432-437, 1985
7. Chu PC, Lin MT, Shian LR, Leu SY: Alterations in physiologic functions and in brain monoamine content in streptozotocin-diabetic rats. Diabetes 35:481-484, 1986
8. Lackovic Z, Salkovic M, Kuci S, Relja M: Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J Neurochem 54:143-147, 1990
9. Welsh B, Wecker L: Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain. Neurochem Res 16:453-460, 1991
10. Mooradian AD: Blood-brain barrier choline transport is reduced in diabetic rats. Diabetes 36:1094-1097, 1987
11. Massicotte G, Baudry M: Triggers and substrates of hippocampal synoptic plasticity. Neuro Biobehav Rev 15:415-423, 1991
12. Morris RGM, Anderson E, Lynch GS, Baudry M: Selective impairment of learning and blockade of long-term potentiation by the N-methyl-D-aspartate receptor antagonist, AP-5. Nature 319:774-776, 1986
13. Staubli U, Thibault O, DiLorenzo M, Lynch G: Antagonism of NMDA receptors impairs acquisition but not retention of olfactory memory. Behav Neurosci 103:54-60, 1989
14. Collingridge GL, Kehl SJ, McLennan H: Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J Physiol 334:33-46, 1983
15. Larson J, Lynch G: Role of N-methyl-D-aspartate receptors in the induction of synaptic potentiation by burst stimulation patterned after the hippocampal theta rhythm. Brain Res 441:111-118, 1988
16. Lynch G, Larson J, Kelso S, Barrionuevo G, Schottler F: Intracellular injections of EGTA block induction of hippocampal long-term potentiation. Nature 305:20-26, 1983
17. Malenka RC, Kauer JA, Zucker RS, Nicoll RA: Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 242:81-84, 1988
18. Davies SN, Lester RA, Reymann KG, Collingridge GL: Temporally distinct pre-and post-synaptic mechanisms maintain long-term potentiation. Nature 338:500-503, 1989
19. Kauer JA, Malenka RC, Nicoll RA: A persistent postsynaptic modification mediates long-term potentiation in the hippocampus. Neuron 1:911-917, 1988
20. Muller D, Joly M, Lynch G: Contributions of quisqualate and NMDA receptors to the induction and expression of LTP. Science 242:1694-1697, 1988
21. Massicotte G, Vanderklish P, Lynch G, Baudry M: Modulation of AMPA/quisqualate receptors by phospholipase A2: a necessary step in long-term potentiation. Proc Natl Acad Sci USA 88:1893-1897, 1991
22. Massicotte G, Kessler M, Lynch G, Baudry M: N-methyl-D-aspartate and quisqualate/AMPA receptors: differential regulation by phospholipase C treatment. Mol Pharmacol 32:278-285, 1990
23. Tocco G, Massicotte G, Standley S, Thompson RF, Baudry M: Effect of temperature and calcium on the binding properties of the AMPA receptor in frozen rat brain sections. Eur J Neurosci 4:1093-1103, 1992
24. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
25. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
26. Nakashima E, Ishizaki J, Takeda M, Matsushita R, Yokogawa K, Ichimura F: Pharmacokinetics of anticholinergic drugs and brain muscarinic receptor alterations in streptozotocin diabetic rats. Biopharm Drug Dispos 14:673-684, 1993
27. 3H-spiroperidol binding in streptozotocin-diabetic rats. J Neurochem 40:1456-1459, 1983
28. Bitar MS, DeSouza EB: Diabetes-related changes in brain beta adrenoreceptors in rats as assessed by quantitative autoradiography: relationship to hypothalamic norepinephrine metabolism and pitutary-gonadal hormone secretion. J Pharmacol Exp Ther 254:781-785, 1990
29. Makar TK, Hungund BL, Cook GA, Kashfl K, Cooper AJL: Lipid metabolism and membrane composition are altered in the brains of type II diabetic mice. J Neurochem 64:2159-2168, 1995
30. Mooradian AD, Dickerson F, Smith TL: Lipid order and composition of synaptic membranes in experimental diabetes mellitus. Neurochem Res 15:981-985, 1990
31. McLean WG, Pekiner C, Cullum NA, Casson IF: Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes. Mol Neurobiol 6:225-237, 1992
32. Normandin M, Gagné J, Bernard J, Élie R, Miceli D, Baudry M, Massicotte G: Involvement of the 12-lipoxygenase pathway of arachidonic acid metabolism in homosynaptic long-term depression of the rat hippocampus. Brain Res 730:40-46, 1996
33. Kovalchuk Y, Miller B, Sarantis M, Attwell D: Arachidonic acid depresses non-NMDA receptor currents. Brain Res 643:287-295, 1994
34. Rosello-Catafau J, Hotter G, Closa D, Ortiz MA, Pou-Torello JM, Gimeno M, Bioque G, Gelpi E: Liver lipoxygenase arachidonic acid metabolites in streptozotocin-induced diabetes in rats. Prostaglandin Leukot Essent Fatty Acids 51:411-413, 1994
35. Rosello-Catafau J, Closa D, Hotter G, Bulbena O, Ortiz MA, Pou-Torello JM, Gimeno MAF, Gelpi E: Pancreas lipoxygenase arachidonic acid metabolites production in streptozotocin-induced diabetes in rats. Horm Metab Res 26:387-388, 1994
36. Nitsch R, Hoyer S: Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 128:199-202, 1991
37. Yakel JL, Vissavajhala P, Derkach VA, Brickey DA, Soderling TR: Identification of a calcium/calmodulin-dependent protein kinase II regulatory phosphorylation site in non-N-methyl-D-aspartate glutamate receptors. Proc Natl Acad Sci USA 92:1376-1380, 1995
38. Nakazawa K, Mikawa S, Hashikawa T, Ito M: Transient and persistent phosphorylation of AMPA-type glutamate receptor subunits in cerebellar purkinje cells. Neuron 15:697-709, 1995
39. Hollman M, Heinemann S: Cloned glutamate receptors. Annu Rev Neurosci 17:31-108, 1994
40. Bi X, Tocco G, Baudry M: Calpain-mediated regulation of AMPA receptors in adult rat brain. Neuroreport 6:61-64, 1994